欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2020, Vol. 25 ›› Issue (8): 943-952.doi: 10.12092/j.issn.1009-2501.2020.08.014

• 综述与讲座 • 上一篇    下一篇

肿瘤治疗中靶向DNA损伤反应

赵文超,邱艳芳,谭嵘   

  1. 分子放射肿瘤学湖南省重点实验室,中南大学湘雅医院,长沙 410008,湖南
  • 收稿日期:2019-10-17 修回日期:2020-07-31 出版日期:2020-08-26 发布日期:2020-09-03
  • 通讯作者: 谭嵘,女,博士,副教授,研究方向:DNA损伤修复。 Tel: 18684660420 E-mail: zizi_tr@126.com
  • 作者简介:赵文超,男,博士研究生,研究方向:DNA损伤修复。 Tel: 18711182572 E-mail: 188101061@csu.edu.cn
  • 基金资助:
    国家自然科学基金面上项目(81974451);湖南省自然科学基金面上项目(2019JJ40482)

Targeting DNA damage response in tumor therapy

ZHAO Wenchao, QIU Yanfang, TAN Rong   

  1. Key Laboratory of Molecular Radiation Oncology Hunan Province, Xiangya Hospital of Central South University, Changsha 410008, Hunan, China
  • Received:2019-10-17 Revised:2020-07-31 Online:2020-08-26 Published:2020-09-03

摘要: 在恶性肿瘤治疗中,化疗作为一种传统治疗方式,发挥着非常重要的作用。随着医学研究的发展,不同种类及不同作用机制的化疗药物先后应用于临床。许多化疗药物使用初期对肿瘤取得了较好的反应疗效,但随着治疗的进展,化疗耐药出现,成为了肿瘤治疗亟待解决的问题。其中,DNA损伤修复能力的改变是产生化疗耐药的重要原因之一。本文主要阐述DNA损伤修复通路的改变与化疗药物耐药之间的关系,并进一步讨论在DNA损伤修复通路缺陷的肿瘤中,如何寻找潜在治疗靶点,通过联合治疗手段克服化疗耐药。

关键词: 肿瘤治疗, DNA损伤, 化疗耐药

Abstract: Chemotherapy plays an important role in cancer treatment. With deeply understanding the mechanism of tumorigenesis, different chemotherapeutic drugs have been emerged as initial choices for cancer treatment. However, most patients gradually develop to chemotherapeutic resistance, resulting in failure to initial standard therapy. The mechanisms of chemoresistance are extensively explored. Recent studies indicated intrinsic or acquired alteration of DNA damage repair ability is the key determinant of chemoresistance. In this review, we present deregulation of DNA damage repair pathway in cancers and its involvement contributing to chemoresistance. Furthermore, we discuss strategies to sensitize chemotherapy by targeting at a parallel DNA repair pathway, which become promising approaches to overcome chemotherapeutic resistance.

Key words: oncotherapy, DNA damage, chemoresistance

中图分类号: